Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban in heparin-induced thrombocytopenia Type II
NCT00861692Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Apr 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of argatroban in Heparin-induced thrombocytopenia type 2, sponsored by Mitsubishi Tanabe Pharma. Started Apr 2009; status: completed.
02
Drugs
argatroban
03
Conditions
Heparin-induced thrombocytopenia type 2
Beyond the preview
Go deeper on NCT00861692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861692.